Current Offering — KB Diversified Healthcare 30, DST

A Multi-Asset Dialysis Portfolio

Southeast U.S. (Georgia, Mississippi, south carolina, texas)

6.00% Distribution (as of 12/31/2019)

Long-term Leases (15 years)

Escalating Rental Schedule

Leases Guaranteed by Fresenius Kidney Care & DaVita, Inc.

Cost Segregation Study for Accelerated Depreciation

Delaware Statutory Trust (DST) Ownership Structure

Equity Investments Starting from $100,000

KB Essential Healthcare 30, DST

KB Exchange Trust is pleased to offer a four-property dialysis portfolio, structured as a Delaware Statutory Trust (DST). This multi-asset portfolio consists of approximately 34,575 square feet located across four Southeastern states. Both tenants are Fortune 500 companies and the #1 and #2 renal care entities in the United States. All of the properties have stipulated rental increases over the anticipated holding period. The Trust has obtained a non-recourse loan structured on a 10-year term at 3.86% with five years interest only and five years of amortization.

About Fresenius

Fresenius Kidney Care, a division of Fresenius Medical Care (NYSE: FMS) is the nation’s leading provider of kidney care, hospital services and renal products. Fresenius is a $22 billion worldwide company with over 120,734 employees and a network of 3,928 dialysis clinics in North America, Europe, Latin America, Asia-Pacific, and Africa. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure. Fresenius is a Fortune 500 Company and serves approximately 3.4 million patients worldwide.

About DaVita

DaVita Inc. (“DaVita”) is the second largest provider of kidney care in the United States and is traded on the New York Stock Exchange (NYSE: DVA). Delivering dialysis services to patients with chronic kidney failure and end-stage renal disease, DaVita is located in nine different countries, 46 states, and the District of Columbia. DaVita also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the US. In 2018, DaVita’s consolidated revenue was approximately $11.4 billion with an operating income of over $1.5 billion. Approximately 90% of DaVita’s 2018 consolidated revenue was derived from their outpatient hemodialysis clinics. DaVita is a Fortune 500 Company and serves approximately 39% of the total dialysis outpatients in the United States.

Download DST Investment Summary

To download the DST investment summary, please select if you are a financial professional or an investor. You can also call us at 314.399.4588 for immediate assistance.



Secure SSL Form


Year Founded 1996
Headquarters Germany
Market Capitalization (as of June 17, 2019) $21.95 billion
Fortune 500 Ranking 313
Total Dialysis Clinics 4,000
Patients in 2018 342,000
Number of Employees 120,000


Year Founded 1992
Headquarters Denver, CO
Market Capitalization (as of June 17, 2019) $8.2 billion
Fortune 500 Ranking 188
Total Dialysis Clinics 2,664
Patients in 2018 202,700
Number of Employees 70,000+